Does TISLELIZUMAB-JSGR Cause Lymphadenopathy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Lymphadenopathy have been filed in association with TISLELIZUMAB-JSGR. This represents 14.0% of all adverse event reports for TISLELIZUMAB-JSGR.
7
Reports of Lymphadenopathy with TISLELIZUMAB-JSGR
14.0%
of all TISLELIZUMAB-JSGR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lymphadenopathy From TISLELIZUMAB-JSGR?
Of the 7 reports.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB-JSGR. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB-JSGR Cause?
Disease progression (15)
Off label use (9)
Anaemia (8)
Pneumonia (8)
Thrombocytopenia (7)
Infusion related reaction (6)
Pyrexia (6)
Death (5)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)